Scope of this article
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
This translation is provided for general access and has no recorded medical-language review.
Editorial general information — not a clinical-review record
Published: Updated: Publisher: Dr. Murat Toktamışoğlu
Blue-grey discoloration after hyaluronic-acid filler is often called the Tyndall effect, although the optical mechanism is disputed. Superficial product, edema, visible vessels, bruising and pigment change may look similar and should not be treated as interchangeable without examination.
This translation has no recorded clinical or medical-language review.
The term Tyndall effect has become common shorthand for a blue appearance over superficially placed HA gel. Optical analyses, however, question whether classical Tyndall or Rayleigh scattering fully describes this complex gel-skin system. A familiar label does not prove one cause. Record whether colour appears only under selected light, whether elevation is present, whether it follows a vessel and how long after injection it began.
Superficial filler may accompany irregularity or palpable gel, while periorbital edema can be diffuse and vary through the day. Bruising evolves through colour stages, whereas pigment change may not blanch. A red reticular pattern, pallor, severe pain or visual symptom should not be observed as a simple colour issue. When product, plane, date, amount or lot is unknown, previous records and, when appropriate, ultrasound can support assessment.
For confirmed HA with suspected superficial placement, a physician can discuss options in relation to severity and the person's goal. Hyaluronidase has allergy and tissue-effect risks of its own, and a permanent, biostimulatory or unknown material behaves differently. Adding filler or energy to conceal colour may obscure the cause. Preserve standardized photographs and follow-up, and do not promise complete correction or absence of a residual mark.
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
These links are editorial starting points used to examine the article's boundaries.
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
D. B. Rootman, J. L. Lin and R. Goldberg · 2014
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Review authors · 2022
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review